Patent Yard Sign in
Canadian application, no grantCanada

Method for enhancing immune responses in mammals

CA 2392137 A1 · Owner: Colorado State University Research Foundation · Inventors: Howell, Mark D.; Selinsky, Cheryl L.; Leber, Leland C.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides a method for enhancing an immune response in a mammal to facilitate the elimination of a chronic pathology. The method involves the removal of immune system inhibitors from the circulation of the mammal, thus, enabling a more vigorous immune response to the pathogenic agent. The removal of immune system inhibitors is accomplished by contacting an acellular component of whole blood, or a fraction thereof of a mammal with , one or more binding partner(s) capable of binding to and thus, depleting the , targeted immune system inhibitor(s) from the biological fluids. Particularly useful in the invention is an absorbent matrix composed of an inert …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 15, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 15, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 15, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 15, 2000
GrantedNo grant recorded
Term endedNovember 15, 2020
Patent numberCA 2392137 A1
Classification (IPC)A61K39/00 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedNov 15, 2000Term endedNov 15, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.